Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jhazmat.2020.124164 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pain, Agitation, Delirium, and Iatrogenic Withdrawal Syndrome Management in Children Who Are Critically Ill: Protocol for a European Clinical Practice Guideline Using the Grading of Recommendations Assessment, Development, and Evaluation Approach.
JMIR Res Protoc
September 2025
Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Background: In pediatric intensive care units, pain, sedation, delirium, and iatrogenic withdrawal syndrome (IWS) must be managed as interrelated conditions. Although clinical practice guidelines (CPGs) exist, new evidence needs to be incorporated, gaps in recommendations addressed, and recommendations adapted to the European context.
Objective: This protocol describes the development of the first patient- and family-informed European guideline for managing pain, sedation, delirium, and IWS by the European Society of Paediatric and Neonatal Intensive Care.
Outcomes of an Online, Interprofessional Stroke Simulation: Mixed Methods Analysis.
J Allied Health
September 2025
Dep. of Medical Education, East Tennessee State University Quillen College of Medicine, PO Box 70582, Johnson City, TN 37614, USA.
Introduction: Educational approaches used in distance learning courses may be applicable to interprofessional education (IPE) simulation events to promote student engagement and learning.
Methods: Various strategies known to be effective when teaching online courses (real world applications, self-directed learning, reliance on previous life experiences, communities of practice, and emotional engagement) were incorporated into an interprofessional simulation event. Learning outcomes were captured quantitatively through student ratings of learning objective accomplishment and qualitatively through thematic analyses of learner reflections.
Clesrovimab: First Approval.
Drugs
September 2025
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Clesrovimab (ENFLONSIA™; clesrovimab-cfor) is a long-acting monoclonal antibody developed by Merck & Co., Inc. to prevent respiratory syncytial virus (RSV) disease in infants.
View Article and Find Full Text PDFComment on: Risk of malignant transformation and infections in congenital lung malformations in adults: a systematic review.
Eur Respir Rev
July 2025
Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Department of Pediatric Surgery, Rotterdam, The Netherlands
https://bit.ly/4eHqwsP
View Article and Find Full Text PDFComment on "Clinical Significance of Biochemical Pregnancy Loss in Recurrent Pregnancy Loss Patients: Insights From Euploid Embryo Transfers Minimizing Embryonic Bias".
Reprod Med Biol
September 2025
Dr. D. Y. Patil Medical College Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University) Pune Maharashtra India.
This commentary addresses Kuwabara et al.'s study on biochemical pregnancy loss (BPL) in recurrent pregnancy loss (RPL) patients following euploid embryo transfers. While their methodology minimizes embryonic bias and strengthens maternal factor assessment, concerns regarding statistical interpretation and potential ascertainment bias limit generalizability.
View Article and Find Full Text PDF